In vivo characterization of a selective FGFR2 inhibitor with potency against gatekeeper and molecular brake mutations

被引：0
|
作者：
Fischer, John
Bouhana, Karyn
Chicarelli, Mark
Fell, Brad
Fulton, Jennifer
Guarnieri, Anna
Haygood, Leyla
Jalluri, Ravi
Johnson, Amber
Mclean, Brent
Mejia, Max
Rieger, Rob
Robinson, John
Rodriguez, Mareli
Sullivan, Francis
Wang, Yang
Winski, Shannon
Zhou, YeYun
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1439
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Identification of a reversible selective FGFR2 clinical development candidate with potency against gatekeeper and molecular brake mutations
    Fischer, John
    Bouhana, Karyn
    Brizendine, Richard
    Chicarelli, Mark
    Fell, Brad
    Fulton, Jennifer
    Guarnieri, Anna
    Haygood, Leyla
    Jalluri, Ravi
    Johnson, Amber
    Koch, Keith
    Koslov-Davino, Erika
    Mejia, Max
    Rieger, Rob
    Robinson, John
    Rodriguez, Mareli
    Sullivan, Francis
    Wang, Yang
    Winski, Shannon
    Wood, Silas
    Zhou, Yeyun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [2] TYRA-200: Potent Against FGFR2 Fusions, Molecular Brake Mutations and Gatekeeper Resistance
    Allen, E.
    Balcer, A.
    Bensen, D.
    Burn, T.
    Hoffman, I.
    Hudkins, R.
    Iyer, S.
    Neal, M.
    Nelson, K.
    Occhino, C.
    Patel, P.
    Starrett, J.
    Swanson, R.
    Ye, Q.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S16 - S16
  • [3] In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations
    Fischer, J.
    Bouhana, K.
    Chicarelli, M. J.
    Dahlke, J.
    Fell, B.
    Fulton, J.
    Guarnieri, A.
    Haygood, L.
    Jalluri, R.
    Johnson, A.
    McLean, B.
    Max, M.
    Rieger, R.
    Robinson, J.
    Rodriguez, M.
    Sullivan, F.
    Wang, Y.
    Winski, S.
    Zhou, Y.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S81 - S81
  • [4] ctDNA-based genomic landscape analysis to evaluate molecular brake and gatekeeper mutations in FGFR2 alterations
    Severson, Paul
    Sytnikova, Julia
    Mohan, Adithi
    Zhang, Nicole
    Donderici, Elifnur Yay
    Williams, Richard Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Pre-clinical characterization of a novel series of FGFR2 selective inhibitors with potency against clinically relevant mutations
    Fischer, John
    Bouhana, Karyn
    Chicarelli, Mark J.
    Dahlke, Josh
    Fell, Brad
    Fulton, Jennifer
    Guarnieri, Anna
    Jalluri, Ravi
    Johnson, Amber
    Mclean, Brent
    Mejia, Max
    Rieger, Rob
    Robinson, John
    Rodriguez, Mareli
    Sullivan, Francis
    Wang, Yang
    Winski, Shannon
    Zhou, Yeyun
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Regulation of the Molecular Brake Region in FGFR2 Kinase
    Karp, Jerome M.
    Cowburn, David
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 530A - 530A
  • [7] RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
    Subbiah, Vivek
    Sahai, Vaibhav
    Maglic, Dejan
    Bruderek, Kamil
    Toure, B. Barry
    Zhao, Songping
    Valverde, Roberto
    O'Hearn, Patrick J.
    Moustakas, Demetri T.
    Schoenherr, Heike
    Gerami-Moayed, Nastaran
    Taylor, Alexander M.
    Hudson, Brandi M.
    Houde, Damian J.
    Pal, Debjani
    Foster, Lindsey
    Gunaydin, Hakan
    Ayaz, Pelin
    Sharon, Dina A.
    Goyal, Lipika
    Schram, Alison M.
    Kamath, Suneel
    Sherwin, Cori Ann
    Schmidt-Kittler, Oleg
    Jen, Kai Yu
    Ricard, Fabien
    Wolf, Beni B.
    Shaw, David E.
    Bergstrom, Donald A.
    Watters, James
    Casaletto, Jessica B.
    CANCER DISCOVERY, 2023, 13 (09) : 2012 - 2031
  • [8] Regulation of the "molecular brake" region in FGFR2 kinase.
    Karp, J. M.
    Cowburn, D.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [9] Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations
    Franovic, Aleksandra
    Mohan, Adithi
    Uryu, Sean
    Wu, Qibiao
    Jiang, Ping
    Miller, Nichol
    Tyhonas, John
    Timple, Noelito
    Severson, Paul
    Kania, Robert
    Murphy, Eric
    Bardeesy, Nabeel
    Martin, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [10] Preclinical characterization of a Selective FGFR2/3 inhibitor, GSC000829
    Han, T.
    Fu, D.
    Cheng, T.
    Xia, Y.
    Hu, Z.
    Yang, F.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S52 - S52
12345